These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4870959)

  • 1. Diphenylhydantoin. Its usefulness in clinical disorders of a non-epileptic nature. Discussion on safety.
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:64-6. PubMed ID: 4870959
    [No Abstract]   [Full Text] [Related]  

  • 2. The usefulness of diphenylhydantoin in treatment of non-epileptic emotional disorders.
    Turner WJ
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:8-20. PubMed ID: 5587569
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

  • 4. Diphenylhydantoin in emotional disorders.
    Livingston S
    JAMA; 1968 May; 204(6):549. PubMed ID: 5694442
    [No Abstract]   [Full Text] [Related]  

  • 5. ACNP--session on diphenylhydantoin: introductory remarks.
    Elkes J
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:6-7. PubMed ID: 5587568
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenytoin (diphenylhydantoin).
    Med Lett Drugs Ther; 1976 Feb; 18(5):23-4. PubMed ID: 1256358
    [No Abstract]   [Full Text] [Related]  

  • 7. The psychoactive properties of diphenylhydantoin: experiences with prisoners and juvenile delinquents.
    Resnich O
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:30-6. PubMed ID: 4873471
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of diphenylhydantoin.
    Simpson JF
    Ann Intern Med; 1973 Feb; 78(2):305-6. PubMed ID: 4683770
    [No Abstract]   [Full Text] [Related]  

  • 9. The diagnostic and therapeutic use of diphenylhydantoin in the subictal state and non-epileptic dysphoria.
    Jonas AD
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:21-9. PubMed ID: 5587566
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of diphenylhydantoin in severe psychiatric disorders.
    Klein DF; Greenberg IM
    Am J Psychiatry; 1967 Dec; 124(6):847-9. PubMed ID: 4862960
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myasthenic syndrome following long-term diphenylhydantoin therapy].
    Milonas J; Kountouris D; Scheer E
    Nervenarzt; 1983 Aug; 54(8):437-8. PubMed ID: 6413870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diphenylhydantoin in the comprehensive treatment of epileptic attacks].
    Kolínová M; Kristof M; Maresová S
    Cesk Neurol Neurochir; 1982 Nov; 45(6):410-7. PubMed ID: 7151206
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic failures in epileptic children due to impaired diphenylhydantoin bioavailability.
    Koren G; Brand N; Daney S; Halkin H
    Isr J Med Sci; 1982 Jun; 18(6):721-3. PubMed ID: 7107212
    [No Abstract]   [Full Text] [Related]  

  • 15. [Association of pyrithioxin and diphenylhydantoin in the treatment of organic epileptic syndromes].
    Martínez-Lage JM; Molina P; Madoz P
    Med Clin (Barc); 1965 Sep; 45(3):204-5. PubMed ID: 5861606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytogenetic study of diphenylhydantoin therapy using SCE].
    Sinués B; Martínez P; Tamparillas M; Bartolomé M
    Arch Farmacol Toxicol; 1982 Dec; 8(3):165-70. PubMed ID: 7183246
    [No Abstract]   [Full Text] [Related]  

  • 17. Presenile cataracts in hydantoin-treated epileptic patients.
    Savir H; Bar S; Feller N
    Metab Pediatr Syst Ophthalmol; 1983; 7(3):169-71. PubMed ID: 6656625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central effect of diphenylhydantoin (Dilantin) in epileptic oligophrenics during phenobarbital-primidone withdrawal, sodium bicarbonate, and ammonium chloride administration.
    Viukari NM; Tammisto P
    Behav Neuropsychiatry; 1969 Nov; 1(8):13-6. PubMed ID: 5407671
    [No Abstract]   [Full Text] [Related]  

  • 19. Central effects of diphenylhydantoin (dilantin) in epileptic oligophrenics during phenobarbital-primidone withdrawal, sodium bicarbonate, and ammonium chloride administration.
    Matti N; Viukari A; Tammisto P
    Behav Neuropsychiatry; 1969 Nov; 1(8):13-6. PubMed ID: 5374542
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Diphenylhydantoin treatment of bulimia.
    Weiss T; Levitz L
    Am J Psychiatry; 1976 Sep; 133(9):1093. PubMed ID: 961937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.